BPG is committed to discovery and dissemination of knowledge
Citation
Kaplan N, Kabatas S, Civelek E, Savrunlu EC, Akkoc T, Boyalı O, Öztürk E, Can H, Genc A, Karaöz E. Multiroute administration of Wharton’s jelly mesenchymal stem cells in chronic complete spinal cord injury: A phase I safety and feasibility study. World J Stem Cells 2025; 17(5): 101675 [PMID: 40503363 DOI: 10.4252/wjsc.v17.i5.101675]
Please LOGIN to submit a new comment.